The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Galena Biopharma Inc

Nasdaq: GALE
Last

(U.S.) $2.83

Today's change+0.09 +3.28%
Updated December 2 4:00 PM -5GMT. Delayed by at least 15 minutes.
 

Galena Biopharma Inc

Nasdaq: GALE
Last

(U.S.) $2.83

Today's change+0.09 +3.28%
Updated December 2 4:00 PM -5GMT. Delayed by at least 15 minutes.

Galena Biopharma Inc up sharply

Galena Biopharma Inc closed up sharply Friday, rallying (U.S.)$0.09 or 3.28% to (U.S.)$2.83. Over the last five days, shares have lost 20.06% and are down 90.37% for the last year to date. This security has underperformed the S&P 500 by 95.65% during the last year.

Key company metrics

  • Open(U.S.) $2.73
  • Previous close(U.S.) $2.74
  • High(U.S.) $2.97
  • Low(U.S.) $2.61
  • Bid / Ask(U.S.) $2.88 / (U.S.) $2.96
  • YTD % change-90.37%
  • Volume1,047,163
  • Average volume (10-day)606,279
  • Average volume (1-month)355,565
  • Average volume (3-month)237,815
  • 52-week range(U.S.) $2.61 to (U.S.) $49.80
  • Beta2.95
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$2.32
Updated December 2 4:00 PM -5GMT. Delayed by at least 15 minutes.

Latest Company News

  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue--------
Total other revenue--------
Total revenue0000
Gross profit--------
Total cost of revenue--------
Total operating expense76913
Selling / general / administrative3343
Research & development4655
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)0-405
Other operating expenses, total--------
Operating income-7-6-9-13
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-48-13-10
Income after tax-48-13-11
Income tax, total------0
Net income-75-16-20
Total adjustments to net income--------
Net income before extra. items-48-13-11
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-48-13-11
Inc. avail. to common incl. extra. items-75-16-20
Diluted net income-75-16-20
Dilution adjustment----0--
Diluted weighted average shares10998
Diluted EPS excluding extraordinary itemsvalue per share-0.410.89-1.46-1.33
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share-0.400.49-1.44-0.91